RCEL
Avita Medical LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$120.34M
P/E Ratio
—
EPS
$-1.56
Beta
1.86
52W High
$7.12
52W Low
$3.22
50-Day MA
$4.39
200-Day MA
$4.27
Dividend Yield
—
Profit Margin
-62.70%
Forward P/E
10.29
PEG Ratio
—
About Avita Medical Ltd
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
Fundamentals
| Revenue (TTM) | $72.35M |
| Gross Profit (TTM) | $58.86M |
| EBITDA | $-37.11M |
| Operating Margin | -45.70% |
| Return on Equity | -1746.00% |
| Return on Assets | -40.80% |
| Revenue/Share (TTM) | $2.50 |
| Book Value | $-0.55 |
| Price-to-Book | 11.77 |
| Price-to-Sales (TTM) | 1.66 |
| EV/Revenue | 2.165 |
| EV/EBITDA | -6.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.00% |
| Shares Outstanding | $30.78M |
| Float | $30.30M |
| % Insiders | 1.50% |
| % Institutions | 17.15% |
Historical Volatility
HV 10-Day
43.68%
HV 20-Day
59.83%
HV 30-Day
58.69%
HV 60-Day
70.21%
HV Rank
19.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.09 target)
3
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026